Mortality and Hospitalization Risk Following Oral Androgen Signaling Inhibitors Among Men with Advanced Prostate Cancer by Pre-existing Cardiovascular Comorbidities
Grace Lu-Yao, Nikita Nikita, Scott W. Keith, Ginah Nightingale, Krupa Gandhi, Sarah E. Hegarty, Timothy R. Rebbeck, Andrew Chapman, Philip W. Kantoff, Jennifer Cullen, Leonard Gomella, William Kevin Kelly
Dive into the research topics of 'Mortality and Hospitalization Risk Following Oral Androgen Signaling Inhibitors Among Men with Advanced Prostate Cancer by Pre-existing Cardiovascular Comorbidities'. Together they form a unique fingerprint.